Certified by Founder
Lodge
hema.to GmbH
start up
Germany
- Munich
- 07/03/2025
- Unknown
- $3,900,060
We are a deeptech AI company obsessed with solving cytometry and thereby make an outsized and lasting impact on immune medicine: we want to make sure every patient gets the right treatment at the right time for their unique immune systems.
- Industry Software Development
- Website https://www.hema.to/
- LinkedIn https://www.linkedin.com/company/hemato/
Related People
Karsten MiermansFounder
Germany -
Munich, Bavaria
Founder of an AI diagnostic start-up, passionate about improving cytometry and blood cancer diagnostics. I have a background in theoretical biophysics, but I'm a generalist at heart. My fundamental drivers are growth, honesty, efficiency and curiosity. In my spare time, I enjoy reading great works, electronic music and teaching rationality.
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)